Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT)
NCT01525095 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 700
Last updated 2014-06-09
Summary
The purpose of this study is to assure the uniform collection, handling, storage and transport of patient whole blood specimens and associated information to support validation of the T2 Candida Assay.
Conditions
- Candidemia
Sponsors & Collaborators
-
T2 Biosystems
lead INDUSTRY
Principal Investigators
-
Peter Pappas, MD · University of Alabama at Birmingham
Eligibility
- Min Age
- 18 Years
- Max Age
- 95 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2013-12-31
- Completion
- 2014-03-31
Countries
- United States
Study Locations
More Related Trials
-
Evaluate the Performance of Genetic Amplification by Polymerase Chain Reaction (PCR) and the "Mannan Antigenemia and Antimannan Antibodies Couple as a Means of Diagnosis and a Marker of Follow-up in Invasive Candidiasis.
NCT02333448 ·Status: COMPLETED
-
Clinical Outcomes in Candidemia Patients Based on in Vitro Susceptibility
NCT01077336 ·Status: COMPLETED
-
Early- and Late-onset Candidemia
NCT01406093 ·Status: COMPLETED
-
A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)
NCT01174147 ·Status: COMPLETED
-
Invasive Candidiasis in Critical Care
NCT06456151 ·Status: RECRUITING
-
Changing Patterns of Candida Infections in Urban Medical Centers
NCT00366223 ·Status: COMPLETED
-
Evaluation of Rapid Diagnostic Device for the Detection of Candida Auris
NCT07253311 ·Status: NOT_YET_RECRUITING
-
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
NCT00002325 ·Status: COMPLETED ·Phase: NA
-
The Impact of Rapid Diagnostic Methods in the Diagnosis of Fungal Infections in Intensive Care Units of Assiut University Hospital
NCT05876962 ·Status: UNKNOWN
-
Funguria in Hospitalized Patients
NCT00138502 ·Status: COMPLETED
-
TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.
NCT00740389 ·Status: COMPLETED ·Phase: PHASE1
-
Biofilm Formation and Antifungal Resistance in Candida Species
NCT07245563 ·Status: NOT_YET_RECRUITING
-
A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia
NCT01982071 ·Status: TERMINATED ·Phase: PHASE4
-
Retrospective Chart Review of Candida Fungemia
NCT03827330 ·Status: COMPLETED
-
Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis
NCT00923832 ·Status: COMPLETED
-
Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis
NCT00904995 ·Status: COMPLETED ·Phase: PHASE3
-
Immunological Interaction Between the Host and Candida Albicans Biofilm
NCT01919931 ·Status: COMPLETED
-
Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease
NCT00462657 ·Status: UNKNOWN ·Phase: NA
-
Studies of Disorders With Increased Susceptibility to Fungal Infections
NCT01222741 ·Status: RECRUITING
-
CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis
NCT02629419 ·Status: COMPLETED ·Phase: PHASE2
-
Antigenic and Antibody Detection of Candida
NCT03766932 ·Status: UNKNOWN
-
Interest of Real-time Polymerase Chain Reaction (PCR) in the Diagnosis of Fungal Infections
NCT00876096 ·Status: COMPLETED ·Phase: NA
-
Optimized Diagnostics for Improved Therapy Stratification in Invasive Fungal Infections
NCT02492594 ·Status: COMPLETED
-
Diagnostic Study of Combined Biomnarker Testing in Bronchoalveolar Lavage Samples of Immunocompromised Patients
NCT01695512 ·Status: UNKNOWN
-
Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant
NCT00445952 ·Status: COMPLETED